- August 31, 2022, the U.S. Food and Drug Administration authorized Pfizer’s and Moderna’s bivalent
boosters, which will be available to those who have received the primary two-dose series
- Pfizer is releasing a bivalent injection targeting Omicron subvariants BA.4 and BA.5, which are the two currently in circulation. Moderna’s bivalent booster targets the already extinct Wuhan strain and Omicron subvariant BA.1
- The reformulated COVID
boosters(they are Brand new) will be rolled out without safety or effectiveness data from human trials. They’re being green-lighted based on antibody data from mice alone, even though antibody levels tell us nothing about effectiveness
- According to the FDA, the reactogenicity profile of Pfizer’s reformulated shot is “overall similar to prototype BNT162b2 vaccine,” and VAERS data prove that’s hardly a selling point
- This fall, health agencies will also push the seasonal flu shot, and all flu vaccines will be quadrivalent this year, meaning they contain antigens against four influenza strains. Seniors may be at greatest risk for vaccine injury, as they will get a high-dose quadrivalent flu vaccine
VIDEO: The Jimmy More Show-COVID
Booster Brand New shot Approved Authorized For Emergency Use Despite ZERO Human Testing
First off, these new shots are not “boosters”. They are brand new concoctions.
From Bill Gates himself:
We didn’t understand the fatality rate. We didn’t understand that it’s a fairly low fatality rate and that it’s a disease mainly of the elderly kind of like flu is but a bit different than that.
Oh yes WE did Bill.
As the U.S., U.K. and other countries around the world prepare for a fall vaccination campaign against both the flu and COVID, it’s worth taking note of some basic facts. In “Untested Bivalent COVID Jab Being Rolled Out,” I reviewed potential problems with Moderna’s new bivalent COVID shot for adults, authorized by the U.K. in mid-August 2022.
August 23, 2022, Pfizer and Moderna submitted their respective authorization requests to the U.S. Food and Drug Administration. Pfizer is releasing a bivalent injection targeting Omicron subvariants BA.4 and BA.5, which are the two currently in circulation, while Moderna’s shot targets the already extinct Wuhan strain and Omicron subvariant BA.1.
August 31, the FDA authorized both. The bivalent boosters will only be available to those who have already received the primary two-dose series and/or a monovalent booster at least two months ago. Per the FDA:
“The Moderna COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 18 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 12 years of age and older …
With today’s authorization, the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older … These monovalent vaccines continue to be authorized for use for administration of a primary series for individuals 6 months of age and older …
Individuals 18 years of age and older are eligible for a single booster dose of the Moderna COVID-19 Vaccine, Bivalent if it has been at least two months since they have completed primary vaccination or have received the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine.
Individuals 12 years of age and older are eligible for a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent if it has been at least two months since they have completed primary vaccination or have received the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine.”
The reformulated boosters will be available as soon as the U.S. Centers for Disease Control and Prevention gives its OK. For the record, all boosters, including these, are still under emergency use authorization (EUA) only, so manufacturers have no liability for injuries, and the reformulated shots are being released based on antibody levels in mice alone.
It was only authorized for emergency use. That is VERY different from approval, and a VERY important distinction that needs to be made.
VIDEO: US Funded Research On “Coronavirus Induced Myocarditis”, FDA Authorized New Jab & The Green Police
@ 50:00 Ryan Cristián/TheLastAmericanVagabond breaks down the new shots along with all the source material
An FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval without key data
To help the drugmakers hit that fall deadline, the FDA said the companies did not need to include data from a clinical trial.
Many Are Bailing on Never-Ending Boosters
According to The New York Times:
“The Biden administration has struggled to convince Americans of the need for successive vaccinations. Only about two-thirds of the population has been inoculated with the primary series of two shots, and far fewer have received booster doses.”
According to the latest U.S. Centers for Disease Control and Prevention statistics, 262,643,277 Americans have received at least one COVID shot (79.1% of the total population); 108,540,822 have received a first booster dose (48.5%) and 36,323,498 have taken a second booster (33.7%).
But wait, there’s more. As best we can tell, you will not be allowed to get this “new and improved” COVID jab unless you already had your initial two jabs and are double boosted. You simply will not qualify, as they want everyone to get as much of the spike proteins as they can. We won’t know for sure, though, until after the CDC meets this week to decide.
The fact that far fewer people are continuing with the booster madness is a good sign, as it suggests people are finally realizing that the COVID shots aren’t safe OR effective. The entire point of a vaccine is to render you immune against future infection, and getting a booster every three to six months clearly speaks to the failure of these injections to provide any worthwhile protection.
Most COVID cases, especially serious infections, are now also occurring among the “vaccinated,” which further undermines their allure. Only the most brainwashed fail to rethink after having COVID two or three times despite being fully vaxxed and boosted, which today is not a rare event.
According to MSN, 40% of Americans hospitalized with a SARS-CoV-2 subvariant are fully vaxxed and boosted. Excess mortality statistics also tell a story, with age-adjusted all-cause excess mortality (deaths above the expected norm) nearly tripling since the rollout of the COVID jabs in mid-December 2020.
Vaccine Performance Is Not Dependent on Frequency of Use
It remains to be seen how government and media intend to bully people into continuing with this clearly failed strategy, but if The Atlantic is any indication, we can expect Orwellian double-speak and irrational emotionalism to prevail.
According to The Atlantic, “Vaccine performance … depends on how and how often the shots are used. The more people take the doses, the better they will work.” This is merely blatant and outrageous propaganda whose sole purpose is to increase COVID jab adoption. As noted by one Twitter user, that’s complete rubbish, as “The performance of a ‘vaccine’ should have NOTHING to do with everyone ELSE taking it.”
The statement that vaccine performance depends on “how often” they’re taken is also clearly misleading if not outright false. No vaccine in history has depended on boosters several times a year, indefinitely. That’s not how real vaccines work. Historically, vaccine booster doses are spaced years apart, if they’re required at all.
New Formulation Is Only Tested on Mice
VIDEO: ……CDC Pushes Untested New Injections & The Coming Mask Mandates For Flu
@ 1:51:00 Ryan Cristián/TheLastAmericanVagabond Again breaks down the new shots along with more source material
Novel bivalent C-19 vaccines: What does common immunological sense predict in regard to their impact on the C-19 pandemic?
Bivalent mRNA booster candidates have been developed as a next step in the development of C-19 vaccines to combat the virus; these new vaccines target the induction of a broader immune response than the original vaccines and have to some extent already been approved by regulatory authorities (e.g., FDA, MHRA).
One wonders though why studies conducted to test these new vaccines have only enrolled baseline seronegative participants whereas the new vaccines will predominantly be administered to people who have already been vaccinated with first generation C-19 vaccines. This is quite striking as usage of these updated C-19 vaccines to fight dominantly circulating Omicron variants in previously C-19-vaccinated populations is highly contra-indicated as it violates all basic principles of vaccinology.
Updated C-19 vaccines comprising new mRNA- or protein-derived S-associated sequences of one or more Omicron (sub)variants will only further deteriorate the already dire consequences of C-19 mass vaccination—abundant cell surface-expressed and/ or free circulating S protein will cause a unilateral and potentially protracted recall of IEABs without priming neutralizing Abs against new Omicron-specific antigenic sequences in the vast majority of healthy vaccinees. Whereas the purpose of these novel vaccines is to enhance protection against continuously evolving variants, they will have exactly the opposite effect, in that they will enhance the evolutionary dynamics of the virus. Continued mass vaccination with novel Omicron-adapted vaccines will only increase population-level immune pressure on viral virulence by the IEABs (which currently have a virulence-inhibiting effect at the level of the lower respiratory tract). Large scale vaccination with these updated vaccines will merely expedite natural selection and expansion of SC-2 variants that will exhibit a high level of virulence and infectiousness in vaccinees, while sparing the unvaccinated from this impact.
To me what is most scary is that from the point of view of the White House, Ashish is doing a good job as he pushes misleading messages, false statements and allows Pfizer to basically run the FDA. Approval based on 8 mice for 18 yo men is crazy. Pushing it hard. Even crazier. https://t.co/o2U0OLt20a
— Vinay Prasad MD MPH (@VPrasadMDMPH) September 7, 2022
Please share this, pass it along,
comment and start a conversation.